In contrast, TAMs may promote the secretion of various factors associated with tumor progression and metastasis, including tumor necrosis factor α (TNF-α), IL-6, transforming growth factor α (TGF-α), platelet-derived growth factor receptor (PDGFR), and vascular endothelial growth factor receptor (VEGFR). Here, IL6 is linked to neoplasm.